science
Scientists discover why ozempic may not work for some people
Why this matters: new research or scientific developments with potential real-world impact.
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significa
Read full story on Science Daily → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Science Daily alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop